Open AccessResponse Guided Treatment with Telaprevir or Boceprevir in End Stage Renal Disease Patients with Hepatitis C Genotype 1
Author(s) -
Anish Patel,
Seth N. Sclair,
Omer Junaidi,
Violet Copado,
Cynthia Levy,
Paul Martin,
Madhavi Rudraraju,
Kalyan Bhamidimarri
Publication year - 2014
Publication title -
journal of gastroenterology and hepatology research
Language(s) - English
Resource type - Journals
eISSN - 2224-6509
pISSN - 2224-3992
DOI - 10.17554/j.issn.2224-3992.2014.03.470
Subject(s) - boceprevir , telaprevir , medicine , ribavirin , daclatasvir , gastroenterology , regimen , pegylated interferon , itpa , hepatitis c , end stage renal disease , anemia , tolerability , adverse effect , hepatitis c virus , disease , immunology , virus